UnitedHealth Stock And 2 Healthcare Names Facing Policy Risk

Voter support is tilting toward democratic socialist policies like universal healthcare, higher taxes on the wealthy, and more government-backed services, and that puts parts of the healthcare sector squarely under the spotlight. For investors, the bigger question is how potential future reforms and tougher oversight could affect margins, pricing power, and long term business models. This article examines the political catalysts behind this shift and then outlines 3 healthcare stocks that appear most exposed to these headlines, all on the risk side of the ledger, so you can evaluate whether they still fit your portfolio.

UnitedHealth Group (UNH)

Overview: UnitedHealth Group is a large US health care company that combines a nationwide health insurance business with pharmacy services and data driven care delivery through its Optum and UnitedHealthcare segments, serving employers, government programs and individuals in the US and abroad.

Market Cap: US$384.5b

Investors looking at UnitedHealth Group need to weigh solid scale advantages and strong Q2 2026 execution against rising political and regulatory heat. The stock screens as cheap on some valuation measures and offers a reliable dividend, yet earnings and margins have come under pressure recently, and analysts highlight funding and credit sensitivity because the company leans heavily on external borrowing. In a world where support for universal healthcare and stricter oversight is building, a major insurer with concentrated exposure to Medicare Advantage and active Department of Justice investigations could see its pricing power and profitability squeezed. The key issue is whether recent AI driven efficiency gains and cost controls can offset mounting policy and regulatory risk over time.

UnitedHealth’s scale and AI efficiency gains might be masking where political and funding risks could really bite next. Get the full context in the 3 key rewards and 1 important warning sign

CVS Health (CVS)

Overview: CVS Health is a large US healthcare company that combines Aetna health insurance plans, a major pharmacy benefit management business, and a nationwide chain of retail pharmacies and online pharmacy services to deliver insurance, prescription fulfillment, and in store health services to consumers, employers, and government programs.

Operations: CVS Health generates most of its revenue in the US, with around US$195.2b from Health Services, US$142.7b from Health Care Benefits, and US$139.4b from Pharmacy & Consumer Wellness, partly offset by US$71.7b of intersegment eliminations and a small Corporate and Other contribution.

Market Cap: US$135.9b

Investors looking at CVS Health may want to be cautious, because the company is leaning harder into politically sensitive areas like Medicare, Medicaid and GLP 1 drug access at a time when voter support for universal healthcare, higher taxes and tougher oversight is rising. Earnings have been under strain, with profit margins at 0.7% and a large US$6.6b one off loss in the recent past, while debt and dividends are not well covered by operating cash flow. In addition, regulators are active, with FTC actions on pharmacy benefit management practices and a US$440m Omnicare settlement highlighting legal and reputational risk. The stock has recently outperformed, although that sits beside relatively expensive headline valuation metrics, insider selling and a relatively inexperienced board that still has to demonstrate it can manage these political and operational fault lines.

CVS Health’s earnings strain, thin 0.7% margins and legal overhangs suggest the recent share price strength may be masking deeper issues. Review the 2 key rewards and 5 important warning signs (1 is major!)

HCA Healthcare (HCA)

Overview: HCA Healthcare is a large US hospital operator that owns and runs a wide network of hospitals, emergency rooms, surgery centers, clinics and other care facilities, providing inpatient and outpatient medical services to communities across the country.

Operations: HCA Healthcare generates about US$76.4b in revenue from its operating hospitals and related healthcare entities, with its American, Atlantic and National groups together contributing the bulk of this figure across regional networks.

Market Cap: US$85.6b

HCA Healthcare attracts interest because it combines improving profitability, with earnings growth of 17.6% and an 8.9% net margin, with a P/E that sits below many peers. However, the story is being clouded by rising political risk and recent guidance cuts. As support builds for universal healthcare and higher corporate taxes, a largely US focused, taxpaying hospital system could face pressure on reimbursement rates and after tax earnings, especially with high leverage and negative shareholders’ equity already on the balance sheet. Recent analyst downgrades tied to payer mix, ACA related headwinds and weaker surgical volumes show how quickly sentiment can turn when policy and business trends move in an unfavorable direction. This is occurring before any more aggressive reforms gain traction with voters.

HCA Healthcare’s improving earnings and lower P/E might be masking how exposed a highly leveraged, taxpaying hospital system is to voter backed reforms that squeeze margins and cash flow, so walk through the full analysis report for HCA Healthcare

Take Control of Your Investment Journey

If HCA Healthcare or any of these companies are making you feel more cautious, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Market narratives move fast and the next breakout list of stocks rarely stays under the radar for long. Use these fresh screens before the crowd and act now.

• Spot under followed quality, then run through the 20 high quality undiscovered gems that filters for strong fundamentals while they are still flying below most investors' attention.
• Lock onto reliable cash generators by scanning the 8 dividend fortresses built to surface high yield payers that aim to keep distributions and balance sheets in better shape.
• Track the AI build out behind the headlines by checking the 53 AI infrastructure stocks that focuses on companies supplying the hardware and backbone for rising computing demand.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com